Cargando…
Molecular Mechanisms of Chemoresistance Induced by Cisplatin in NSCLC Cancer Therapy
Cancer cells utilise several mechanisms to increase their survival and progression as well as their resistance to anticancer therapy: deregulation of growth regulatory pathways by acquiring grow factor independence, immune system suppression, reducing the expression of antigens activating T lymphocy...
Autores principales: | Kryczka, Jolanta, Kryczka, Jakub, Czarnecka-Chrebelska, Karolina H., Brzeziańska-Lasota, Ewa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8396273/ https://www.ncbi.nlm.nih.gov/pubmed/34445588 http://dx.doi.org/10.3390/ijms22168885 |
Ejemplares similares
-
Isothiocyanates (ITCs) 1-(Isothiocyanatomethyl)-4-phenylbenzene and 1-Isothiocyanato-3,5-bis(trifluoromethyl)benzene—Aldehyde Dehydrogenase (ALDH) Inhibitors, Decreases Cisplatin Tolerance and Migratory Ability of NSCLC
por: Kryczka, Jolanta, et al.
Publicado: (2022) -
The Comparison of Serum Exosome Protein Profile in Diagnosis of NSCLC Patients
por: Baran, Kamila, et al.
Publicado: (2023) -
Respiratory Tract Oncobiome in Lung Carcinogenesis: Where Are We Now?
por: Czarnecka-Chrebelska, Karolina H., et al.
Publicado: (2023) -
Serum Extracellular Vesicle-Derived miRNAs in Patients with Non-Small Cell Lung Cancer—Search for Non-Invasive Diagnostic Biomarkers
por: Kryczka, Jolanta, et al.
Publicado: (2021) -
A Strong Decrease in TIMP3 Expression Mediated by the Presence of miR-17 and 20a Enables Extracellular Matrix Remodeling in the NSCLC Lesion Surroundings
por: Czarnecka, Karolina H., et al.
Publicado: (2019)